BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

#advertisement

12th Aging Research & Drug Discovery Meeting

Latest News

Lantern Pharma Launches AI Platform for Blood-Brain …

Lantern Pharma Launches AI Platform for Blood-Brain Barrier Permeability Prediction, Completes Japan Trial Enrollment

Lantern Pharma has announced two major milestones: completion of patient enrollment in Japan for its Phase 2 HARMONIC trial of LP-300 in never-smokers with non-small … Read More

Ultromics Gets $55M to Spot Hidden Heart …

Ultromics Gets $55M to Spot Hidden Heart Failure with AI Ultrasound

Oxford-based Ultromics has secured $55 million in Series C funding to expand deployment of its AI-powered echocardiography software across the U.S. and globally. The company … Read More

Synchron Becomes First to Achieve Native Thought-Control …

Synchron Becomes First to Achieve Native Thought-Control of Apple iPad Using Brain-Computer Interface

The New York-based medtech Synchron, a brain-computer interface (BCI) company backed by DARPA, Gates Frontier, and Bezos Expeditions, has become the first to publicly demonstrate … Read More

Neuralink Begins UK Clinical Trial of Brain Implant for People with Paralysis

OpenAI-Backed Ambience Raises $243M in Series C, Reaching $1B+ Valuation

Profluent Publishes AI-Designed Genome Editor in Nature, Releases Largest CRISPR Dataset

AI-Native Formation Bio Licenses Monoclonal Antibody After $372M Raise in 2024

Modi Ventures Closes $88M Second Fund for AI–Biology Convergence Investments

Latent Labs Launches Web-Based AI Tool for Custom Protein Generation

Read latest news ›››

Latest Insights

The Future of Advanced Therapeutics: Opportunities and …

by Sai Bhamidipati

The Future of Advanced Therapeutics: Opportunities and Challenges

The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities … Read More

Marking the Path Ahead: Integrating Oncology Biomarkers …

by Bea Mann, PhD

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical trials and onto the market. … Read More

"AI Scientists"—New Collaborators for Rare Disease Research?

by Louise von Stechow

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

by Louise von Stechow

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

by Dominik Tomicevic

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Read all insights ›››

From Our Partners

Read All ›››

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

Unlocking Interoperability with AI: How This Company …

Sponsored by Trialize

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

Partner Events

View all events ›››

The 12th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

Case Studies

Read All ›››

ArtiDock from Receptor.AI: Next-generation AI Docking That …

Sponsored by RECEPTOR.AI

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Bioz Badges — Advanced Data-Widgets for Confident …

Sponsored by Bioz

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Biocompare: Offline Order Attribution Analysis Helps Demonstrate …

Sponsored by Biocompare

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Interviews

Read All ›››

The Synergistic Potential of AI and Synthetic …

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Navigating Next Wave of Protein Design with …

Navigating Next Wave of Protein Design with Elise de Reus from Cradle

Targeted Protein Degradation: a New Approach to …

Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics

Most Read

ArtiDock from Receptor.AI: Next-generation AI Docking That …

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Top AI in Pharma and Healthcare Conferences …

Top AI in Pharma and Healthcare Conferences in 2024 You Can’t Miss

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

Insilico Medicine’s Generative AI Patent Provides Advantage …

Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race